Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Omega Healthcare Investors Q3 2026 Results: Net Income $83.1M, Down 53.8% YoY

Omega Healthcare Investors reported a significant increase in total revenues to $991.8 million for the nine months ended September 30, 2026, compared to $870.9 million in the prior year. Net income available to common stockholders rose to $597.0 million, driven largely by a $249.1 million gain on assets sold.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue340.6311.6
Profit before tax85.4191.3
Net income83.1179.7
EPS (diluted, $ a share)$0.27$0.59

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-53.8%
Revenue, year on year+9.3%
Source

10-Q filed with the SEC, NYSE: OHI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Omega Healthcare Investors Inc: key numbers

Share price
$47.08Close, Nov 16
Market cap
$14.3B
Shares outstanding
304.33MLatest SEC cover page
Sector
Real Estate & Construction
Industry
Real Estate Investment TrustsSIC 6798

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Omega Healthcare Investors Inc

All →
4:17 PM ET 8-K
Financial Results

Omega Healthcare Investors Financial Results

Omega Healthcare Investors reported Q3 2026 net income of $87 million and Adjusted FFO of $0.82 per share. The company raised its full-year 2026 AFFO guidance midpoint to $3.29 per share following $1.5 billion in year-to-date investment activity, including a significant post-quarter transition of 32 Florida facilities to PACS Group.

Term
Q3 2026

“We are pleased to report strong third quarter results, as we continued to grow FAD per share year over year, while reducing leverage to the lowest level in the Company’s history. As a result, we were again able to increase our AFFO guidance, moving the midpoint up by five cents to $3.29.”

Matthew Gourmand, Omega’s Chief Executive Officer

“The investments made in the third and early fourth quarter highlight the breadth of opportunities available to us to continue to grow shareholder value. The pipeline remains strong, and we expect to make further accretive investments through the remainder of this year and into early 2027.”

Matthew Gourmand, Omega’s Chief Executive Officer
6:03 AM ET 8-K
Business Update

Omega Healthcare Investors Business Update

Omega Healthcare Investors transitioned the operations of 32 skilled nursing facilities in Florida from Airamid Health Services to PACS Group. The transition is expected to increase annual rent by $26.1 million in the first year and $2.5 million in the second year, though Omega incurred a one-time expense of approximately $90 million to facilitate the move.

Counterparty
PACS Group, Inc.
8:20 AM ET 8-K
Leadership Change

Omega Healthcare Investors Leadership Change

Matthew P. Gourmand has been appointed as President and Chief Executive Officer of Omega Healthcare Investors, succeeding C. Taylor Pickett upon his retirement. Mr. Gourmand was also appointed to the Board of Directors to fill the vacancy created by Mr. Pickett's departure, effective October 1, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.